SCHEMBL14375898

SCHEMBL14375898

Cc1ccc(NC(=O)c2ccc(CNC(=O)C3(C)CC4(C)CC(C)(C3)C(=O)NC4=O)cc2)cc1Nc1ncccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 12/20 0.51
▸ KIT P10721 11/20 0.51
▸ KDR P35968 2/20 0.49
▸ ABL1 P00519 12/20 0.46
▸ BCR P11274 10/20 0.45
▸ LRRK2 Q5S007 1/20 0.45
▸ ABL2 P42684 2/20 0.44
▸ PDGFRB P09619 4/20 0.44
▸ EGFR P00533 2/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ DDX3X O00571 1/20 0.44
▸ GAK O14976 1/20 0.44
▸ SLC22A2 O15244 1/20 0.44
▸ MAPK13 O15264 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ SLC22A3 O75751 1/20 0.44
▸ ABCB11 O95342 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14375923 0.92 ABL1 (0.43) PDGFRAKITKDRABL1BCR
SCHEMBL14375872 0.89 PDGFRA (0.60) PDGFRAKITKDRABL1BCR
SCHEMBL14375833 0.88 PDGFRA (0.71) PDGFRAKITKDRABL1BCR
SCHEMBL14375835 0.85 MAPK14 (0.48) PDGFRAKITKDRABL1BCR
SCHEMBL14375949 0.81 NAMPT (0.43) NAMPT
SCHEMBL14375912 0.77 NAMPT (0.52) NAMPT
SCHEMBL14375882 0.76 PDGFRA (0.51) PDGFRAKITKDRABL1BCR
SCHEMBL14375783 0.75 PDGFRA (0.51) PDGFRAKITKDRABL1BCR
SCHEMBL14375896 0.72 PDGFRA (0.55) PDGFRAKITKDRABL1BCR
SCHEMBL12943127 0.72 PDGFRA (0.55) PDGFRAKITKDRABL1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279576-B2 Anti-cancer medicaments DECIPHERA PHARMACEUTICALS, LLC (US) 2007-10-09 — — US disclosed
Send feedback